Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00024115)National Cancer Institute (NCI)
A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers. (NCT00000846)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals (NCT00001042)National Institute of Allergy and Infectious Diseases (NIAID)
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) (NCT01048983)M.D. Anderson Cancer Center
Bioequivalence Study of Torrent Pharmaceutical Limited's ISMN 120 mg ER Tablets Under Fasting Condition (NCT01418534)Torrent Pharmaceuticals Limited
Pharma-Pen (Formerly Innoject) Auto-injectory TIV (NCT00335855)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Study of Delayed-Type Hypersensitivity (DTH) Reactions to Intradermal HIV Envelope Antigen (NCT00000782)National Institute of Allergy and Infectious Diseases (NIAID)
Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females (NCT02245945)CONRAD
Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting Conditions (NCT00939497)Torrent Pharmaceuticals Limited
Chemotherapy With DNA Damaging Agents In Colorectal Cancer (NCT01456923)Centro Hospitalar Nordeste
A Study of 1592U89 in HIV-Infected Patients (NCT00002388)Glaxo Wellcome
The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients. (NCT00000629)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex (NCT00000675)National Institute of Allergy and Infectious Diseases (NIAID)
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00004114)Jonsson Comprehensive Cancer Center
Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function (NCT00528216)NeurogesX
A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 (NCT00000972)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents (NCT01596088)Kissei Pharmaceutical Co., Ltd.
Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients (NCT00002403)Aronex Pharmaceuticals
Bioequivalence Study of Torrent Pharmaceuticals Ltd's Bioequivalence Study of Torrent Pharmaceuticals Ltd's Quetiapine Tablets Under Fasting Conditions (NCT01634386)Torrent Pharmaceuticals Limited
Bioequivalence Study of Torrent Pharmaceutical Limited's Donepezil Hydrochloride Tablets Under Fed Conditions (NCT01419366)Torrent Pharmaceuticals Limited
Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children (NCT00055107)National Institute of Allergy and Infectious Diseases (NIAID)
TNFerade Biologic to Treat Locally Advanced Prostate Cancer (NCT01048151)GenVec
A Study of Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis (NCT00508768)Scios, Inc.
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma (NCT00319683)Adherex Technologies, Inc.
Botswana Study of UC-781 Vaginal Microbicide (NCT00385554)Centers for Disease Control and Prevention
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers (NCT00001072)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals (NCT00001026)National Institute of Allergy and Infectious Diseases (NIAID)
A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma (NCT00733798)TransMolecular
A Study of 141W94 in Combination With Other Anti-HIV Drugs (NCT00002372)Glaxo Wellcome
Study Evaluating MST-997 in Advanced Malignant Solid Tumors (NCT00277836)Wyeth is now a wholly owned subsidiary of Pfizer
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Montelukast Sodium Chewable 5mg Tablet Under Fed Conditions (NCT01931514)Torrent Pharmaceuticals Limited
Human Immune Responses Smallpox (NCT00068198)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition (NCT01996475)Torrent Pharmaceuticals Limited
A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator. (NCT00280358)Dey
A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients (NCT00001010)National Institute of Allergy and Infectious Diseases (NIAID)
The Effect of Vision Therapy/Orthoptic on Motor & Sensory Status of the 3 to 7 Years Old Strabismic Patients (NCT00917982)Shahid Beheshti University of Medical Sciences
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis (NCT00002316)Alkermes, Inc.
A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients (NCT00002383)Hoffmann-La Roche
A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers (NCT00000808)National Institute of Allergy and Infectious Diseases (NIAID)
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors (NCT00080041)Pharmacyclics LLC.
A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss (NCT00000854)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Zidovudine in HIV-Infected Patients With Kidney Problems (NCT00000685)National Institute of Allergy and Infectious Diseases (NIAID)
Clonidine for Neurocognitive Sequelae (NCT00166686)Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence (NCT01011686)Anterogen Co., Ltd.
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. (NCT00002139)Pfizer
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days (NCT00002136)Daiichi Pharmaceuticals
A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants (NCT00000887)National Institute of Allergy and Infectious Diseases (NIAID)
Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women (NCT00044837)National Institute of Allergy and Infectious Diseases (NIAID)
The Effect of Stomach Acid on Foscarnet (NCT00000964)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons (NCT00000743)National Institute of Allergy and Infectious Diseases (NIAID)
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease (NCT00060515)Repligen Corporation
A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients (NCT00002218)Parke-Davis
A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection (NCT00000762)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Losartan Potassium (100 mg Tablet) [Test Formulation, Torrent Pharmaceuticals Ltd., India] Versus Cozaar® (100 mg Tablet) [Reference Formulation, Merck & Co. Inc., USA] in Healthy Human Volunteers Under Fasting Condition (NCT01218022)Torrent Pharmaceuticals Limited
Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women (NCT00000809)National Institute of Allergy and Infectious Diseases (NIAID)
Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis (NCT00051662)XOMA (US) LLC
Administration of Increased Dose of GnRH Antagonist for Coasting for Decreasing the Risk for Ovarian Hyperstimulation Syndrome( OHSS) (NCT01109888)Wolfson Medical Center
A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood (NCT00000941)National Institute of Allergy and Infectious Diseases (NIAID)
A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001037)National Institute of Allergy and Infectious Diseases (NIAID)
Study for Safety and Efficiency of Therapeutic Angiogenesis for Patients With Limb Ischemia by Transplantation of Human Cord Blood Mononuclear Cell (NCT00518934)Samsung Medical Center
Bioequivalence Study of Metformin Hydrochloride Extended Release 500 mg Tablet Versus Glucophage XR® 500 mg Tablet in Healthy Volunteers Under Fed Conditions (NCT01089179)Torrent Pharmaceuticals Limited
Investigate a Pharmacodynamics Between S-pantoprazole 10, 20, 40mg and Pantoprazole 20, 40mg in Healthy Male Subjects (NCT01882296)Ahn-Gook Pharmaceuticals Co.,Ltd
The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children (NCT00001054)National Institute of Allergy and Infectious Diseases (NIAID)
Feasibility of Treatment of Cancer Involving the Liver With High Dose Radiation (NCT00178243)University of Rochester
A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patients With Head and Neck Cancer (NCT00496535)GenVec
Modification of the "Edmonton Protocol" to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the "Edmonton Protocol" to Kidney Transplant Recipients (NCT00021580)National Center for Research Resources (NCRR)
Impact of Transcranial Direct Current Stimulation on Fatigability and Fatigue Induced by a Selective Attention Task (NCT02840214)University of Colorado, Denver
Investigation of Cannabis for Pain and Inflammation in Lung Cancer (NCT02675842)New York State Psychiatric Institute
CS DNA MVA Trial in Mampong, Ghana (NCT00377494)National Institute of Allergy and Infectious Diseases (NIAID)
Effects of BufferGel and PRO 2000/5 Gel in Men (NCT00016536)National Institute of Allergy and Infectious Diseases (NIAID)
A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions (NCT00992238)Padagis LLC
Phase I/II Trial of Intracerebral IL13-PE38QQR Infusions in Pediatric Patients With Recurrent Malignant Glioma (NCT00378235)INSYS Therapeutics Inc
A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers (NCT00000813)National Institute of Allergy and Infectious Diseases (NIAID)
Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer (NCT00780988)Stanford University
A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy (NCT00000673)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of L-735,524 in HIV-Positive Children and Adolescents (NCT00002351)Merck Sharp & Dohme LLC
Evaluation of the Effects of Oxygen Therapy and Enalapril for Diabetic Macular Ischemia (NCT00899587)Shahid Beheshti University of Medical Sciences
Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients (NCT00306514)Cytos Biotechnology AG
Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma (NCT00036140)Pfizer
Comparative Bioavailability Study of Metformin HCl 1000 mg Granules vs Glucophage 1000 mg Film-coated Tablet (NCT02217670)Disphar International B.V.
A Study of Azithromycin in HIV-Infected Patients (NCT00002344)Pfizer
A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers (NCT00000868)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting Conditions (NCT00944242)Torrent Pharmaceuticals Limited
A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3 (NCT00000779)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of ADH300004 in Surgically Resected Primary or Metastatic Colorectal Cancer and Liver Biopsy, or Planned Hepatic Resection (NCT00264446)Adherex Technologies, Inc.
A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease. (NCT00000856)National Institute of Allergy and Infectious Diseases (NIAID)
Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People (NCT00099645)National Institute of Allergy and Infectious Diseases (NIAID)
Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) (NCT00109499)GenVec
Phase I Trial of S-1153 in Patients With HIV Infection (NCT00002214)Lexigen Pharmaceuticals
A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children (NCT00000952)National Institute of Allergy and Infectious Diseases (NIAID)
A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients (NCT00000973)National Institute of Allergy and Infectious Diseases (NIAID)
Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults (NCT01970449)National Institute of Allergy and Infectious Diseases (NIAID)
Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 (NCT00000348)National Institute on Drug Abuse (NIDA)
A Study of LXR015-1 in HIV-Infected Patients (NCT00002365)LXR Biotechnology
A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas (NCT00080054)Pharmacyclics LLC.
Bioequivalence Study of Torrent Pharmaceutical Ltd.'s Olanzapine Orally Disintegrating 5mg Tablets Under Fed Condition (NCT01996501)Torrent Pharmaceuticals Limited
Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites (NCT00000826)National Institute of Allergy and Infectious Diseases (NIAID)
Bioequivalence Study of Torrent Pharmaceutical Limited's Pantoprazole Sodium 40 mg Delayed Release Tablets Under Fed Conditions (NCT01418443)Torrent Pharmaceuticals Limited
The Safety and Effectiveness of Nevirapine Plus Nelfinavir in HIV-1 Infected Patients Who Have Taken Stavudine (NCT00002381)Boehringer Ingelheim
Evaluation of the Safety and Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Femoral Fractures (NCT01687530)RegeneCure, Ltd.
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.